TScan Therapeutics (TCRX) Non Operating Income (2022 - 2026)
TScan Therapeutics' Non Operating Income was -$54,000 in Q3 2026, compared with $1.34 million a year earlier.
TScan Therapeutics (TCRX) Non Operating Income (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, TScan Therapeutics' Non Operating Income was $1.43 million through Sep 30, 2026, down 76.4% year-over-year; for FY2025, it was $6.05 million, down 17.4% from FY2024.
- Non Operating Income shows a four-year compound annual growth rate of 340.9% (FY2021 to FY2025).
- In earlier years, Non Operating Income was $7.32 million in FY2024 (+72.7%), $4.24 million in FY2023 (+921.7%), $415,000 in FY2022 and $16,000 in FY2021.
- The Q3 2026 figure marks the lowest quarterly Non Operating Income since Q4 2022.
- Compared with a year earlier, Non Operating Income was higher in 1 of the last seven quarters, with an average decline of 32.8%.
- The best year-over-year quarter for Non Operating Income over five years was Q1 2024 (growth of 583.9%); the worst was Q2 2026 (a decline of 92.1%).
- Per Business Quant data, TCRX's Non Operating Income in the three quarters before Q3 2026 was $134,000 (Q2 2026), $473,000 (Q1 2026) and $881,000 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -15,526.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | -202.00 Mn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | - |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | - |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | - |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | TScan Therapeutics | 18.87 Mn | -434.83 Mn | - | -54,000.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -54,000.00 |
| Jun 30, 2026 | 134,000.00 |
| Mar 31, 2026 | 473,000.00 |
| Dec 31, 2025 | 881,000.00 |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 1.70 Mn |
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 903,000.00 |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | 2.45 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 1.74 Mn |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 565,000.00 |
| Mar 31, 2023 | 180,000.00 |
| Dec 31, 2022 | -74,000.00 |
| Sep 30, 2022 | 333,000.00 |
| Jun 30, 2022 | 149,000.00 |
| Mar 31, 2022 | 7,000.00 |
TScan Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=TCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();